Stock market today: Sensex, Nifty 50 gain nearly 0.50% each on rally in banks, financials; pharma stocks top gainers
The Indian stock market rebounded on March 17, with financials, pharma, and auto stocks driving gains. The Nifty 50 rose 0.50 ...
Analytics Insight10d
Sun Pharma Stock: Is the 28.72% Potential Upside Realistic?
Sun Pharma is a top-ranked Indian pharmaceutical firm. The company’s stock has been continuously in the news lately for ...
Why Johnson & Johnson (JNJ) is the Best Pharma Stock to Buy According to Hedge Funds
We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Is Pfizer Inc. (PFE) the Best Pharma Stock to Buy According to Hedge Funds?
We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...
UroGen Pharma (NASDAQ:URGN) Price Target Cut to $55.00 by Analysts at HC Wainwright
UroGen Pharma (NASDAQ:URGN – Get Free Report) had its price target decreased by equities researchers at HC Wainwright from ...
Walgreens stock gets a modest boost after the pharmacy chain agrees to be bought by private equity
Pharmacy chain Walgreens has agreed to be purchased by private equity firm Sycamore Partners. Premarket shares rose modestly.
Sun Pharma Share Price Highlights: Sun Pharma Stock Price History
Welcome to the Sun Pharma Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock.
Checkpoint Agrees To Sun Pharma Buyout: This Deal Suits Both Parties
Checkpoint Therapeutics is being acquired by Sun Pharmaceutical for $4.10 per share. Learn why CKPT stockholders could earn ...
Pharma and banking stocks gained, while oil & gas, IT and FMCG stocks slipped.
Shares of SBI Life, Bajaj Finserv, Dr Reddy’s Laboratories, Trent and Axis Bank emerged among top gainers of Nifty 50 pack, ...
Stock market update: Nifty Pharma index advances 1.56%
The Nifty Pharma index closed on a positive note on Monday. Shares of Dr. Reddy's Laboratories Ltd.(up 3.86 per cent), ...
US Bancorp DE Decreases Stock Holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO)
US Bancorp DE reduced its stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 55.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The ...